A Massachusetts Man Says Ozempic Blinded Him. Now the FDA Requires a NAION Warning on Every GLP-1.
Published on: 08/11/2026
The FDA now requires a NAION vision-loss warning on every GLP-1, including Ozempic, Wegovy and Zepbound. What the data shows and what prescribers should do.
NAIONFDA GLP-1 warningOzempic blindness lawsuitsemaglutide NAIONtirzepatide NAIONGLP-1 vision lossWegovy side effectsZepbound side effectscompounded semaglutidecompounded tirzepatideMDL 3163optic nerve strokeGLP-1 informed consentGLP-1 label changepeptide safety


